Coty Inc.: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 9, 2023 and accepted by EDGAR at May 9, 2023, 16:46 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $1.29bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-07-01 to 2023-03-31 | $4.20bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-01 to 2023-03-31 | $478.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-07-01 to 2023-03-31 | $1.50bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-01-01 to 2023-03-31 | $810.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-07-01 to 2023-03-31 | $2.70bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-01-01 to 2023-03-31 | $720.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-07-01 to 2023-03-31 | $2.15bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $43.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-07-01 to 2023-03-31 | $414.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $65.2m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-07-01 to 2023-03-31 | $187.8m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $29.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-07-01 to 2023-03-31 | $138.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $108.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-07-01 to 2023-03-31 | $475.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-07-01 to 2023-03-31 | $0.54 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-07-01 to 2023-03-31 | $0.55 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 865,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-07-01 to 2023-03-31 | 885,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-07-01 to 2023-03-31 | $520.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-07-01 to 2023-03-31 | $156.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2022-07-01 to 2023-03-31 | $10.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-03-31 | $245.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $1.91bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $12.71bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $2.76bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $8.57bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $4.22bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-03-31 | $68.3m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2023-03-31 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-03-31 | $3.74bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001024305-23-000036. Last ingested by Listed: Nov 5, 2026, 18:58 ET. Listed shows no prices and gives no investment advice.